New Lab Facilities extend OOC Contract Research Capabilities

Organ-on-a-chip (OOC) company CN Bio a designer and manufacturer of single-and multi-organ microphysiological systems (MPS), has announced the opening of new laboratory facilities at Cambridge Science Park. This move has doubled the company’s laboratory space as a response to the increasing market demand for OOC services as its MPS technology gains traction within drug discovery and development programmes. Using generated data for its customers, the team collaborates with researchers to create an experimental design that delivers unique human-translatable insights, whilst saving significant time and cost versus animal studies.

The rising demand for these services demonstrates acceptance of OOC data by pharma and biotech companies in their therapeutic programmes. This is being fuelled by repeat business, growing interest from regulatory agencies, the technology’s ability to predict clinical outcomes and its potential to replace animal models - especially for the testing of new drug modalities with human-specific modes of action.

Dr Gareth Guenigault, Lead Scientist of CN Bio’s Contract Research Services, said: “This expansion is an exciting next step in the progression of our contract research services offering. As we see increasing awareness within the drug discovery, development and regulatory fields that animal models don’t always get it right, nor are ethically desirable, we are poised to offer solutions that fit researchers’ individual needs. By utilising the power of OOC technology to provide early stage, clinically translatable data across a range of applications, we hope to give customers greater confidence in the success of their projects, in a fraction of the time and cost.”

More information online